Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. Our Company/
      3. Our societal impact /
      4. Global Health Equity /
      5. Why drug-resistant TB matters to the world
      Professor Madhukar Pai, Director of McGill Global Health Programs, speaking on camera during segment on efforts to combat drug-resistant tuberculosis
      Global Health Equity

      Why drug-resistant TB matters to the world

      May 9, 2019
      May 9, 2019

      Beyond its devastating impact on human lives, DR-TB takes a tremendous economic toll. The EIU analysis shows that, based on current incidence and prevalence rates, DR-TB deaths in a single year are estimated to cost the global economy at least US $17.8 billion.

      Learn more about the report here.